Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!

EMD-43795

Single-particle
3.6 Å
EMD-43795
3D View Gallery
Deposition: 23/02/2024
Map released: 06/11/2024
Last modified: 11/12/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-43795
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 9arv summary report (pdf.gz) Map and 9arv FULL report (pdf.gz)
EMICSS annotations (xml)

CryoEM structure of AMETA-A3

EMD-43795

Single-particle
3.6 Å
EMD-43795
3D View Gallery
Deposition: 23/02/2024
Map released: 06/11/2024
Last modified: 11/12/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens
Sample: Adaptive Multi-Epitope Targeting and Avidity-Enhanced (AMETA) Nanobody Platform
Fitted models: 9arv

Deposition Authors: Huang W, Sang Z, Taylor D
Adaptive multi-epitope targeting and avidity-enhanced nanobody platform for ultrapotent, durable antiviral therapy.
Xiang Y , Xu J , McGovern BL, Ranzenigo A, Huang W, Sang Z, Shen J, Diaz-Tapia R, Pham ND, Teunissen AJP, Rodriguez ML, Benjamin J , Taylor DJ, van Leent MMT, White KM, Garcia-Sastre A, Zhang P, Shi Y
(2024) Cell , 187 , 6966 - 6980.e23
PUBMED: 39447570
DOI: doi:10.1016/j.cell.2024.09.043
ISSN: 1097-4172